{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:39:41Z","timestamp":1778769581607,"version":"3.51.4"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mass drug administration (MDA) is a powerful tool for malaria control, but the medicines to use, dosing, number of rounds, and potential selection of drug resistance remain open questions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two monthly rounds of artemisinin-piperaquine (AP), each comprising 2 daily doses, were administered across the 7 districts of Grande Comore Island. In 3 districts, low-dose primaquine (PMQLD) was also given on the first day of each monthly round. Plasmodium falciparum malaria rates, mortality, parasitemias, adverse events, and genetic markers of potential drug resistance were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Average population coverages of 80%\u201382% were achieved with AP in 4 districts (registered population 258 986) and AP + PMQLD in 3 districts (83 696). The effectiveness of MDA was 96.27% (95% confidence interval [CI], 95.27%\u201397.06%; P &amp;lt; .00001) in the 4 AP districts and 97.46% (95% CI, 94.54%\u201398.82%; P &amp;lt; .00001) in the 3 AP + PMQLD districts. In comparative statistical modeling, the effectiveness of the 2 monthly rounds on Grande Comore Island was nearly as high as that of 3 monthly rounds of AP or AP + PMQLD in our earlier study on Anjouan Island. Surveys of pre-MDA and post-MDA samples showed no significant changes in PfK13 polymorphism rates, and no PfCRT mutations previously linked to piperaquine resistance in Southeast Asia were identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MDA with 2 monthly rounds of 2 daily doses of AP was highly effective on Grande Comore Island. The feasibility and lower expense of this 2-month versus 3-month regimen of AP may offer advantages for MDA programs in appropriate settings.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ofid\/ofad076","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T18:07:29Z","timestamp":1676398049000},"source":"Crossref","is-referenced-by-count":10,"title":["Malaria Control by Mass Drug Administration With Artemisinin Plus Piperaquine on Grande Comore Island, Union of Comoros"],"prefix":"10.1093","volume":"10","author":[{"given":"Changsheng","family":"Deng","sequence":"first","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanting","family":"Wu","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Yuan","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-8084","authenticated-orcid":false,"given":"Guoming","family":"Li","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoqin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7216-5942","authenticated-orcid":false,"given":"Mingqiang","family":"Li","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixiang","family":"Tan","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Nadia","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danhong","family":"Feng","sequence":"additional","affiliation":[{"name":"Science and Technology Park, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Li","sequence":"additional","affiliation":[{"name":"Science and Technology Park, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibing","family":"Wu","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"},{"name":"First Affiliated Hospital, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Li","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"},{"name":"First Affiliated Hospital, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[{"name":"Science and Technology Park, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9374-6706","authenticated-orcid":false,"given":"Johannes S P","family":"Doehl","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3246-3248","authenticated-orcid":false,"given":"Xinzhuan","family":"Su","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Affane","family":"Bacar","sequence":"additional","affiliation":[{"name":"National Malaria Center of The Union of Comoros , Moroni , The Union of Comoros"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9074-094X","authenticated-orcid":false,"given":"Kamal","family":"Said Abdallah","sequence":"additional","affiliation":[{"name":"National Malaria Center of The Union of Comoros , Moroni , The Union of Comoros"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafidhou","family":"Mohamed","sequence":"additional","affiliation":[{"name":"National Malaria Center of The Union of Comoros , Moroni , The Union of Comoros"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahamada","family":"Msa Mliva","sequence":"additional","affiliation":[{"name":"National Malaria Center of The Union of Comoros , Moroni , The Union of Comoros"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3899-8454","authenticated-orcid":false,"given":"Thomas E","family":"Wellems","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Song","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"},{"name":"First Affiliated Hospital, Guangzhou University of Chinese Medicine , Guangzhou, Guangdong , People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"2023031017555393700_","volume-title":"Mass drug administration for falciparum malaria: a practical field manual","author":"World Health Organization (WHO)","year":"2017"},{"key":"2023031017555393700_","volume-title":"Mass drug administration, mass screening and treatment and focal screening and treatment for malaria","author":"World Health Organization (WHO) Evidence Review Group","year":"2015"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12916-021-02214-y","article-title":"The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China","volume":"20","author":"Yang","year":"2022","journal-title":"BMC Med"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12936-017-1854-4","article-title":"Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage","volume":"16","author":"Pell","year":"2017","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12936-017-1982-x","article-title":"Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar","volume":"16","author":"Ali","year":"2017","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1016\/S2214-109X(17)30220-6","article-title":"Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study","volume":"5","author":"Brady","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12936-019-2906-8","article-title":"Mass drug administration can be a valuable addition to the malaria elimination toolbox","volume":"18","author":"Eisele","year":"2019","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/14787210.2015.1031744","article-title":"Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance","volume":"13","author":"von Seidlein","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1038\/nature16039","article-title":"Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies","volume":"528","author":"Wu","year":"2015","journal-title":"Nature"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.meegid.2015.04.018","article-title":"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005\u20132013","volume":"33","author":"Morris","year":"2015","journal-title":"Infect Genet Evol"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/infdis\/jiu655","article-title":"Mass screening and treatment on the basis of results of a Plasmodium falciparum\u2013specific rapid diagnostic test did not reduce malaria incidence in Zanzibar","volume":"211","author":"Cook","year":"2015","journal-title":"J Infect Dis"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/cid\/ciy870","article-title":"Mass drug administration with dihydroartemisinin-piperaquine and malaria transmission dynamics in The Gambia: a prospective cohort study","volume":"69","author":"Mwesigwa","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"e51773","DOI":"10.7554\/eLife.51773","article-title":"Determinants of MDA impact and designing MDAs towards malaria elimination","volume":"9","author":"Gao","year":"2020","journal-title":"eLife"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"e20179","DOI":"10.1371\/journal.pone.0020179","article-title":"The potential contribution of mass treatment to the control of Plasmodium falciparum malaria","volume":"6","author":"Okell","year":"2011","journal-title":"PLoS One"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ncomms2241","article-title":"Factors determining the occurrence of submicroscopic malaria infections and their relevance for control","volume":"3","author":"Okell","year":"2012","journal-title":"Nat Commun"},{"key":"2023031017555393700_","article-title":"Mass drug administration for malaria","volume":"2013","author":"Poirot","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.pt.2003.08.003","article-title":"Mass administrations of antimalarial drugs","volume":"19","author":"von Seidlein","year":"2003","journal-title":"Trends Parasitol"},{"key":"2023031017555393700_","article-title":"Mass drug administration for malaria","volume":"9","author":"Shah","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"106209","DOI":"10.1016\/j.actatropica.2021.106209","article-title":"Historical experiences on mass drug administration for malaria control and elimination, its challenges and China\u2019s experience: a narrative review","volume":"225","author":"Nadia","year":"2022","journal-title":"Acta Trop"},{"issue":"Suppl 1","key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"P50","DOI":"10.1186\/1475-2875-13-S1-P50","article-title":"Community-directed malaria freedom on Aneityum Island, Vanuatu, 1991\u20132014","volume":"13","author":"Kaneko","year":"2014","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4269\/ajtmh.19-0659","article-title":"Impact of four rounds of mass drug administration with dihydroartemisinin-piperaquine implemented in Southern Province, Zambia","volume":"103","author":"Eisele","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2023031017555393700_","first-page":"368","article-title":"Epidemiology and control of malaria in the Federal Islamic Republic of Comoros [in French]","volume":"5","author":"Ouledi","year":"1995","journal-title":"Sante"},{"key":"2023031017555393700_","first-page":"90","article-title":"One-year report on the fast elimination of malaria by source eradication (FEMSE) project in Moheli Island of Comoros","volume":"27","author":"Li","year":"2010","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"key":"2023031017555393700_","first-page":"1670","article-title":"Large-scale artemisinin-piperaquine mass drug administration with or without primaquine dramatically reduces malaria in a highly endemic region of Africa","volume":"67","author":"Deng","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023031017555393700_","volume-title":"World malaria report 2014","author":"World Health Organization (WHO) Global Malaria Programme","year":"2014"},{"key":"2023031017555393700_","author":"World Bank Group","year":"2021"},{"key":"2023031017555393700_","first-page":"971","article-title":"Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisinin combination therapies for acute uncomplicated falciparum malaria","volume":"38","author":"Krudsood","year":"2007","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2023031017555393700_","first-page":"908","article-title":"Dosage exploring of artemisinin-piperaquine in treatment of uncomplicated falciparum malaria","volume":"12","author":"Song","year":"2008","journal-title":"Chin J New Drugs Clin Rem"},{"key":"2023031017555393700_","first-page":"1","article-title":"Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand","volume":"39","author":"Tangpukdee","year":"2008","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2023031017555393700_","first-page":"78","article-title":"Efficacy and safety of artemisinin-piperaquine (Artequick) compared to dihydroartemisinin-piperaquine (Artekin) in uncomplicated falciparum malaria in adults","volume":"21","author":"Pyar","year":"2009","journal-title":"Myanmar Health Sci Res J"},{"key":"2023031017555393700_","first-page":"405","article-title":"Tolerance of oral artemisinin-piperaquine tablets in Chinese healthy volunteers","volume":"25","author":"Tan","year":"2009","journal-title":"Chin J Clin Pharmacol"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11655-009-0189-6","article-title":"A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malaria","volume":"15","author":"Trung","year":"2009","journal-title":"Chin J Integr Med"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1475-2875-10-231","article-title":"Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area","volume":"10","author":"Song","year":"2011","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1475-2875-11-217","article-title":"The efficacy and tolerability of artemisinin-piperaquine (Artequick(R)) versus artesunate-amodiaquine (Coarsucam) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam","volume":"11","author":"Thanh","year":"2012","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/AAC.06232-11","article-title":"Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria","volume":"56","author":"Salman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2023031017555393700_","first-page":"197","article-title":"Clinical trial of Artequick-primaquine for the treatment of 155 falciparum malaria patients in Comoros","volume":"2","author":"Deng","year":"2012","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.clinthera.2015.05.035","article-title":"Efficacy, safety and tolerability study of artemisinin-piperaquine combination (Artequick) versus artemeter-lumefantrine (Co-Artem) for the treatment of uncomplicated Plasmodium falciparum malaria in Ijebu Ode local government health services in Nigeria","volume":"37","author":"Onasanya","year":"2015","journal-title":"Clin Ther"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"562363","DOI":"10.3389\/fphar.2020.562363","article-title":"Efficacy and safety of artemisinin-piperaquine for the treatment of uncomplicated malaria: a systematic review","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fphar.2020.00784","article-title":"Surveillance of the efficacy of artemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria among children under 5 years of age in Est-Mono District, Togo, in 2017","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023031017555393700_","first-page":"177","article-title":"Epidemiological stratification of malaria in the Comoro archipelago [in French]","volume":"92","author":"Blanchy","year":"1999","journal-title":"Bull Soc Pathol Exot"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1475-2875-9-57","article-title":"Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine","volume":"9","author":"Song","year":"2010","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat Commun"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12936-020-03339-w","article-title":"Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization","volume":"19","author":"Boonyalai","year":"2020","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/jiab055","article-title":"Distribution and temporal dynamics of P. falciparum chloroquine resistance transporter mutations associated with piperaquine resistance in northern Cambodia","volume":"224","author":"Shrestha","year":"2021","journal-title":"J Infect Dis"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12936-019-2916-6","article-title":"Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?","volume":"18","author":"Foguim Tsombeng","year":"2019","journal-title":"Malar J"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004057","article-title":"The interaction between seasonality and pulsed interventions against malaria in their effects on the reproduction number","volume":"11","author":"Griffin","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001339","article-title":"G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map","volume":"9","author":"Howes","year":"2012","journal-title":"PLoS Med"},{"key":"2023031017555393700_","author":"World Health Organization","year":"2015"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/infdis\/jiy014","article-title":"Safety of single-dose primaquine in G6PD-deficient and G6PD-normal males in Mali without malaria: an open-label, phase 1, dose-adjustment trial","volume":"217","author":"Chen","year":"2018","journal-title":"J Infect Dis"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"638885","DOI":"10.3389\/fphar.2021.638885","article-title":"G6PD variants and haemolytic sensitivity to primaquine and other drugs","volume":"12","author":"Bancone","year":"2021","journal-title":"Front Pharmacol"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12916-022-02504-z","article-title":"Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data","volume":"20","author":"Stepniewska","year":"2022","journal-title":"BMC Med"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(03)15162-8","article-title":"International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis","volume":"363","author":"Adjuik","year":"2004","journal-title":"Lancet"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/tmi.12458","article-title":"Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles","volume":"20","author":"Warsame","year":"2015","journal-title":"Trop Med Int Health"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1473-3099(14)70777-7","article-title":"Artemisinin resistance in Plasmodium falciparum","volume":"14","author":"Amaratunga","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"12513","DOI":"10.1073\/pnas.1813386115","article-title":"Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model","volume":"115","author":"S\u00e1","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023031017555393700_","volume-title":"Status report on artemisinin and ACT resistance","author":"World Health Organization (WHO)","year":"2015"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s13071-015-1253-z","article-title":"Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy","volume":"8","author":"Huang","year":"2015","journal-title":"Parasit Vectors"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3201\/eid2701.203527","article-title":"Increase in kelch 13 polymorphisms in Plasmodium falciparum, southern Rwanda","volume":"27","author":"Bergmann","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","article-title":"A review of the frequencies of Plasmodium falciparum kelch 13 artemisinin resistance mutations in Africa","volume":"16","author":"Ndwiga","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","article-title":"Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda","volume":"13","author":"Tumwebaze","year":"2022","journal-title":"Nat Commun"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chom.2008.06.001","article-title":"Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion","volume":"4","author":"Hayton","year":"2008","journal-title":"Cell Host Microbe"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4269\/ajtmh.2003.69.593","article-title":"Adaptation of a strain of Plasmodium falciparum from Ghana to Aotus lemurinus griseimembra, A. nancymai, and A. vociferans monkeys","volume":"69","author":"Sullivan","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/infdis\/jiac365","article-title":"Mutant PfCRT can mediate piperaquine resistance in African Plasmodium falciparum with reduced fitness and increased susceptibility to other antimalarials","volume":"226","author":"Wicht","year":"2022","journal-title":"J Infect Dis"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"e0240174","DOI":"10.1371\/journal.pone.0240174","article-title":"Effect of mass dihydroartemisinin-piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance","volume":"15","author":"Gupta","year":"2020","journal-title":"PLoS One"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/jac\/dkab281","article-title":"Efficacy of dihydroartemisinin\/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaounde, Cameroon","volume":"76","author":"Mairet-Khedim","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(21)00557-0","article-title":"Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia","volume":"22","author":"Dabira","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023031017555393700_","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12936-017-2027-1","article-title":"Control of malaria in the Comoro Islands over the past century","volume":"16","author":"Chakir","year":"2017","journal-title":"Malar J"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad076\/49179776\/ofad076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/3\/ofad076\/49504560\/ofad076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/3\/ofad076\/49504560\/ofad076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T08:08:23Z","timestamp":1679731703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad076\/7036576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad076","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,2,14]]},"article-number":"ofad076"}}